Allocation concealment in randomised trials: defending against deciphering (Q34116070)

31 July 2017

1 reference

title

Allocation concealment in randomised trials: defending against deciphering (English)

1 reference

31 July 2017

2

David A Grimes

1 reference

31 July 2017

Kenneth F Schulz

1

1 reference

PubMed ID

11867132

31 July 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

31 July 2017

5

1 reference

inferred from page(s)

published in

The Lancet

1 reference

31 July 2017

359

1 reference

31 July 2017

614-618

1 reference

31 July 2017

9306

1 reference

Comparing like with like: some historical milestones in the evolution of methods to create unbiased comparison groups in therapeutic experiments.

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907750-4

7 January 2021

Generation of allocation sequences in randomised trials: chance, not choice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907750-4

7 January 2021

Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907750-4

7 January 2021

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907750-4

7 January 2021

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907750-4

7 January 2021

The Landscape and Lexicon of Blinding in Randomized Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907750-4

7 January 2021

Subverting randomization in controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907750-4

7 January 2021

Meta-analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co-operative trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907750-4

7 January 2021

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907750-4

7 January 2021

Systematic reviews in health care: Assessing the quality of controlled clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907750-4

7 January 2021

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907750-4

7 January 2021

Understanding controlled trials. Randomisation methods: concealment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907750-4

7 January 2021

Randomised trials, human nature, and reporting guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907750-4

7 January 2021

Randomisation and baseline comparisons in clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907750-4

7 January 2021

Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907750-4

7 January 2021

Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907750-4

7 January 2021

Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907750-4

7 January 2021

Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907750-4

7 January 2021

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907750-4

7 January 2021

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907750-4

7 January 2021

How well are randomized controlled trials reported in the dermatology literature?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907750-4

7 January 2021

Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907750-4

7 January 2021

Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907750-4

7 January 2021

Statistical properties of randomization in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907750-4

7 January 2021

Designs for experiments--parallel comparisons of treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907750-4

7 January 2021

10.1016/S0140-6736(02)07750-4

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11867132